RxDoctor Payments Data

Jessica Harnisch-Boyd, DO

Family Medicine · Kellogg, IDNPI 1407319841

Payments from drug & device makers

$690in general payments, 2019–2025

Across 33 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$184
  • Exact Sciences$108
  • Otsuka America Pharmaceutical, Inc.$79
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52
  • GSK$43
  • Bayer$37
  • plus $187 from 8 others

What the payments were for

  • Food & beverage$690100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$690 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$28,169
Medicare patients
94
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TriumeqAbacavir/Dolutegravir/Lamivudi12$42,941
OzempicSemaglutide35$38,027
EliquisApixaban27$30,778
TivicayDolutegravir Sodium13$28,873
DescovyEmtricitabine/Tenofov Alafenam13$28,168
TrulicityDulaglutide24$24,453
JardianceEmpagliflozin18$16,827
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$12,620
FarxigaDapagliflozin Propanediol14$10,019
Lamotrigine ErLamotrigine14$1,891
Pregabalin66$1,141
Levothyroxine Sodium137$939
Celecoxib25$870
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$856
Metoprolol Succinate64$850

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Viiv Healthcare CompanyTriumeq, Tivicay$23$71,81425 claims
Novo NordiskOzempic$15$38,02735 claims
PfizerEliquis$34$30,77827 claims
Lilly USA, LLCTrulicity$19$24,45324 claims
GSKTrelegy Ellipta$43$12,62018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.

Other family medicine in Kellogg

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →